Maintenance fees coming due
10 maintenance fees come due in the 12 months from Nov 21, 2026, the next on Jan 18, 2027. Unpaid by Jul 19, 2027, that one lapses early.
A maintenance fee does not end a patent on its due date. It falls due at 3.5, 7.5
and 11.5 years from grant, and the patent lapses only if the fee is still unpaid at the end of the
six month grace period that follows.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Fee due | Lapses if unpaid | Expires | Confidence |
|---|---|---|---|---|---|---|---|
| US 11,701,331 | Toxic Aldehyde Related Diseases and Treatment In force Fee due Jan 18, 2027 Lapses if unpaid Jul 19, 2027 · Medium confidence | Aldeyra Therapeutics, Inc. | In force | Jan 18, 2027 | Jul 19, 2027 | Medium confidence | |
| US 10,414,732 | Polymorphic Compounds and Uses Thereof In force Fee due Mar 17, 2027 Lapses if unpaid Sep 17, 2027 · High confidence | Aldeyra Therapeutics, Inc. | In force | Mar 17, 2027 | Sep 17, 2027 | High confidence | |
| US 10,426,790 | Treatment of Allergic Eye Conditions with Cyclodextrins In force Fee due Apr 1, 2027 Lapses if unpaid Oct 1, 2027 · High confidence | Aldeyra Therapeutics, Inc. | In force | Apr 1, 2027 | Oct 1, 2027 | High confidence | |
| US 11,771,664 | Toxic Aldehyde Related Diseases and Treatment In force Fee due Apr 3, 2027 Lapses if unpaid Oct 4, 2027 · Medium confidence | Aldeyra Therapeutics, Inc. | In force | Apr 3, 2027 | Oct 4, 2027 | Medium confidence | |
| US 11,786,518 | Ophthalmic Formulations and Uses Thereof In force Fee due Apr 17, 2027 Lapses if unpaid Oct 18, 2027 · High confidence | Aldeyra Therapeutics, Inc. | In force | Apr 17, 2027 | Oct 18, 2027 | High confidence | |
| US 11,845,722 | Deuterated Compounds and Uses Thereof In force Fee due Jun 19, 2027 Lapses if unpaid Dec 20, 2027 · High confidence | Aldeyra Therapeutics, Inc. | In force | Jun 19, 2027 | Dec 20, 2027 | High confidence | |
| US 10,543,181 | Toxic Aldehyde Related Diseases and Treatment In force Fee due Jul 28, 2027 Lapses if unpaid Jan 28, 2028 · High confidence | Aldeyra Therapeutics, Inc. | In force | Jul 28, 2027 | Jan 28, 2028 | High confidence | |
| US 10,550,085 | Deuterated Compounds and Uses Thereof In force Fee due Aug 4, 2027 Lapses if unpaid Feb 4, 2028 · High confidence | Aldeyra Therapeutics, Inc. | In force | Aug 4, 2027 | Feb 4, 2028 | High confidence | |
| US 11,911,385 | Methotrexate Treatment Methods In force Fee due Aug 27, 2027 Lapses if unpaid Feb 28, 2028 · High confidence | Aldeyra Therapeutics, Inc. | In force | Aug 27, 2027 | Feb 28, 2028 | High confidence | |
| US 10,588,874 | Toxic Aldehyde Related Diseases and Treatment In force Fee due Sep 17, 2027 Lapses if unpaid Mar 17, 2028 · Medium confidence | Aldeyra Therapeutics, Inc. | In force | Sep 17, 2027 | Mar 17, 2028 | Medium confidence |
10 of 10 patents shown. Soonest fee due date first, then patent number.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.